Agilent Technologies, Inc. Share Price
Equities
A
US00846U1016
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 140.64 USD | -1.26% |
|
-5.49% | +4.69% |
| Capitalization | 39.81B 34.2B 32.09B 29.9B 55.06B 3,577B 59.84B 372B 145B 1,695B 149B 146B 6,246B | P/E ratio 2025 |
32x | P/E ratio 2026 * | 26.5x |
|---|---|---|---|---|---|
| Enterprise value | 41.44B 35.61B 33.4B 31.13B 57.32B 3,724B 62.29B 387B 151B 1,765B 156B 152B 6,503B | EV / Sales 2025 |
6.2x | EV / Sales 2026 * | 5.61x |
| Free-Float |
99.69% | Yield 2025 * |
0.7% | Yield 2026 * | 0.74% |
Last Transcript: Agilent Technologies, Inc.
| 1 day | -0.27% | ||
| 1 week | -5.49% | ||
| Current month | -8.38% | ||
| 1 month | -4.16% | ||
| 3 months | +11.40% | ||
| 6 months | +20.47% | ||
| Current year | +4.69% |
| 1 week | 140.22 |  | 149.8 |
| 1 month | 140.22 | | 160.27 |
| Current year | 96.43 | | 160.27 |
| 1 year | 96.43 | | 160.27 |
| 3 years | 96.43 | | 160.27 |
| 5 years | 96.43 | | 179.57 |
| 10 years | 34.15 | | 179.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 20/02/2024 | |
Adam Elinoff
DFI | Director of Finance/CFO | 48 | 16/11/2025 |
Joydeep Ganguly
COO | Chief Operating Officer | - | 30/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Boon Hwee Koh
CHM | Chairman | 74 | 15/03/2017 |
George Scangos
BRD | Director/Board Member | 77 | 31/12/2010 |
Daniel Podolsky
BRD | Director/Board Member | 71 | 30/06/2015 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.36% | 26 M€ | +11.19% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.26% | -5.49% | -2.33% | -8.05% | 39.81B | |
| -0.90% | -2.98% | +4.81% | +0.51% | 212B | |
| -1.55% | -1.69% | +3.58% | +106.26% | 198B | |
| -0.56% | -1.48% | -5.37% | -17.12% | 158B | |
| -1.40% | -6.55% | +4.29% | +100.15% | 137B | |
| -1.38% | +2.06% | -19.28% | -14.18% | 56.88B | |
| -1.23% | -1.69% | +17.46% | +12.53% | 48.33B | |
| -0.07% | +3.50% | +1.38% | - | 37.82B | |
| -1.41% | -1.73% | +0.72% | +12.22% | 35.93B | |
| -0.67% | -0.95% | -23.53% | -36.20% | 34.02B | |
| Average | -0.26% | -1.60% | -1.83% | +17.35% | 95.7B | |
| Weighted average by Cap. | -0.26% | -2.29% | +0.42% | +33.57% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 6.92B 5.95B 5.58B 5.2B 9.57B 622B 10.4B 64.69B 25.14B 295B 25.97B 25.42B 1,086B | 7.36B 6.32B 5.93B 5.53B 10.18B 661B 11.06B 68.77B 26.73B 313B 27.61B 27.02B 1,154B |
| Net income | 1.27B 1.09B 1.03B 957M 1.76B 114B 1.91B 11.91B 4.63B 54.25B 4.78B 4.68B 200B | 1.5B 1.29B 1.21B 1.12B 2.07B 134B 2.25B 13.98B 5.44B 63.71B 5.61B 5.5B 235B |
| Net Debt | 1.63B 1.4B 1.32B 1.23B 2.26B 147B 2.45B 15.26B 5.93B 69.52B 6.13B 6B 256B | 1.47B 1.26B 1.18B 1.1B 2.03B 132B 2.2B 13.71B 5.33B 62.45B 5.5B 5.39B 230B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/12/25 | 140.64 $ | -1.26% | 2,324,485 |
| 08/12/25 | 142.44 $ | -2.10% | 2,195,344 |
| 05/12/25 | 145.49 $ | -1.91% | 2,142,102 |
| 04/12/25 | 148.32 $ | -0.63% | 2,865,181 |
| 03/12/25 | 149.26 $ | +0.30% | 2,163,067 |
Delayed Quote Nyse, December 09, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition